olivLaw · US equity research
Streamex Corp. STEX
Security & Commodity Brokers, Dealers, Exchanges & Services · SIC 6200 · Vertical: Security & Commodity Brokers, Dealers, Exchanges & Services (SIC 6200)
Streamex Corp. (formerly BioSig Technologies) has shifted from medical technology toward tokenized real-world asset infrastructure, starting with gold, following a May 2025 acquisition and the 2026 launch of its GLDY product. The company remains in a development stage, with revenue that is not yet significant and large operating losses, so its trajectory depends on product adoption and the regulatory framework.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 05 Nov 2026, Streamex Corp. (STEX) stock was 0.33 USD (−9.70% on the day), with market capitalisation 38.0 m USD, beta 2.22, 52-week range 0.33–4.72 USD. Latest reported quarter (Q2 2026): revenue of 146.0 k USD, net income of -14.6 m USD, diluted EPS -0.08 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 30.5
- weak (30–45)
- Bollinger (20, 2)
- 0.32 – 0.49
- in the lower half of the band · %B 0.05 · band width 42.8%
- SMA 50 / 200
- 0.57 / 1.20
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.06 / -0.06
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −36.9% | −5.9% | −31.0 pp | — |
| 3 months | −54.9% | −4.6% | −50.3 pp | — |
| 6 months | −66.5% | +0.2% | −66.7 pp | — |
| Year to date | −89.2% | +7.4% | −96.7 pp | — |
| 1 year | −93.0% | +8.2% | −101.2 pp | +10.6% |
| 3 years | −92.4% | +68.4% | −160.9 pp | +40.7% |
| 5 years | −99.0% | +56.5% | −155.6 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 ≈ | 13.0 k | — | — | — | — | 12.0 k | 146.0 k |
| Research & development | 156.0 k | 96.0 k | 6.0 k | 19.0 k | 6.0 k | 0 | — | — |
| Operating income | -3.0 m | -1.2 m | -3.0 m | -20.4 m | -6.1 m | -41.6 m | -35.7 m | -15.2 m |
| Depreciation & amortisation | 31.0 k | 30.0 k | 21.0 k | 554.0 k | 1.5 m | 1.5 m | 1.5 m | 1.5 m |
| Interest expense | — | — | — | — | — | — | 12.2 m | — |
| Pre-tax income | -1.9 m | -1.1 m | -2.8 m | -20.4 m | -16.3 m | -424.5 m | -47.3 m | -15.1 m |
| Income tax | — | — | — | — | -765.0 k | -489.0 k | -565.0 k | -505.0 k |
| Net income | -1.9 m | -1.1 m | -2.8 m | -20.4 m | -15.6 m | -424.0 m | -46.7 m | -14.6 m |
| Diluted EPS | -0.12 | -0.06 ≈ | -0.14 | -0.74 | -0.47 | -3.88 ≈ | -0.27 | -0.08 |
| Operating cash flow | -1.5 m ≈ | -474.0 k | -1.1 m | -1.3 m ≈ | -5.0 m ≈ | -3.0 m | -10.2 m | -11.7 m ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | unavailable | unavailable | 0 | 441.0 k | 286.0 k | 18.0 k | 40.0 k | unavailable |
| Revenue YoY | unavailable | unavailable | unavailable | unavailable | −35.1% | −93.7% | +122.2% | unavailable |
| Net income | -18.1 m | -34.1 m | -52.2 m | -31.9 m | -27.1 m | -29.0 m | -10.3 m | -462.8 m |
| Net income YoY | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| Diluted EPS | unavailable | unavailable | unavailable | unavailable | -6.33 | -3.95 | -0.75 | -9.65 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| net % | unavailable | unavailable | unavailable | -7,237.4% | -9,458.7% | -161,338.9% | -25,825.0% | unavailable |
| Free cash flow | -10.3 m | -15.7 m | -26.7 m | -26.9 m | -21.9 m | -17.5 m | unavailable | unavailable |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 20.3 m USD
- Financial debt
- unavailable USD
- Net debt
- unavailable USD
- Equity
- 133.2 m USD
- Total assets
- 187.5 m USD
- Debt / equity
- unavailable
- Current ratio
- 1.68x
- ROE
- unavailable
- ROA
- -491.3%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 441.0 k | 286.0 k | 18.0 k | 40.0 k | — | SEC (XBRL)· 15 Apr 2025verified |
| Cost of revenue | 0 | 199.0 k | 57.0 k | — | — | — | SEC (XBRL)· 31 Mar 2023verified |
| Gross profit | 0 | 242.0 k | 229.0 k | 18.0 k | — | — | SEC (XBRL)· 16 Apr 2024verified |
| Research & development | 18.1 m | 5.6 m | 5.8 m | 5.1 m | 832.0 k | 31.0 k | SEC (XBRL)· 31 Mar 2026verified |
| Operating income | -59.2 m | -33.4 m | -27.3 m | -28.5 m | -12.9 m | -71.1 m | SEC (XBRL)· 31 Mar 2026verified |
| Depreciation & amortisation | 94.0 k | 198.0 k | 293.0 k | 361.0 k | 188.0 k | 3.5 m | SEC (XBRL)· 31 Mar 2026verified |
| EBITDA | -59.1 m ≈ | -33.2 m ≈ | -27.0 m ≈ | -28.2 m ≈ | -12.7 m ≈ | -67.6 m ≈ | SEC (XBRL)· 31 Mar 2026derived |
| Interest expense | — | — | — | — | — | 1.6 m | SEC (XBRL)· 31 Mar 2026verified |
| Pre-tax income | -59.1 m | -32.9 m | -27.3 m | -28.7 m | -10.3 m | -464.0 m | SEC (XBRL)· 31 Mar 2026verified |
| Income tax | 0 | 0 | 0 | — | — | -1.3 m | SEC (XBRL)· 31 Mar 2026verified |
| Net income | -52.2 m | -31.9 m | -27.1 m | -29.0 m | -10.3 m | -462.8 m | SEC (XBRL)· 31 Mar 2026verified |
| Diluted EPS | — | — | -6.33 | -3.95 | -0.75 | -9.65 | SEC (XBRL)· 31 Mar 2026verified |
| Weighted average diluted shares | — | — | 4.3 m | 7.4 m | 14.0 m | 48.0 m | SEC (XBRL)· 31 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 28.3 m | 11.7 m | 400.0 k | 200.0 k | 142.0 k | 20.3 m | SEC (XBRL)· 31 Mar 2026verified |
| Receivables | 0 | 0 | 9.0 k | 24.0 k | 109.0 k | — | SEC (XBRL)· 15 Apr 2025verified |
| Inventories | 768.0 k | 1.9 m | 336.0 k | — | — | — | SEC (XBRL)· 31 Mar 2023verified |
| Current assets | 29.3 m | 13.9 m | 1.1 m | 528.0 k | 388.0 k | 71.9 m | SEC (XBRL)· 31 Mar 2026verified |
| Property, plant & equipment, net | 289.0 k | 652.0 k | 665.0 k | 509.0 k | 85.0 k | 25.0 k | SEC (XBRL)· 31 Mar 2026verified |
| Goodwill | — | — | — | — | — | 71.0 m | SEC (XBRL)· 31 Mar 2026verified |
| Intangibles (excl. goodwill) | 346.0 k | 326.0 k | 307.0 k | 288.0 k | 269.0 k | 44.6 m | SEC (XBRL)· 31 Mar 2026verified |
| Total assets | 30.4 m | 15.5 m | 4.1 m | 1.8 m | 842.0 k | 187.5 m | SEC (XBRL)· 31 Mar 2026verified |
| Accounts payable | 4.7 m | 2.2 m | 2.9 m | 4.1 m | 2.1 m | 3.0 m | SEC (XBRL)· 31 Mar 2026verified |
| Current liabilities | 5.1 m | 2.6 m | 3.3 m | 4.6 m | 2.3 m | 42.8 m | SEC (XBRL)· 31 Mar 2026verified |
| Total liabilities | 5.1 m | 3.0 m | 3.7 m | 4.7 m | 2.3 m | 54.2 m | SEC (XBRL)· 31 Mar 2026verified |
| Equity | 25.2 m | 12.5 m | 292.0 k | -3.0 m | -1.5 m | 133.2 m | SEC (XBRL)· 31 Mar 2026verified |
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -26.6 m | -26.4 m | -21.7 m | -17.3 m | -4.8 m | -10.4 m | SEC (XBRL)· 31 Mar 2026verified |
| Capex | 87.0 k | 542.0 k | 168.0 k | 186.0 k | — | — | SEC (XBRL)· 16 Apr 2024verified |
| Free cash flow | -26.7 m ≈ | -26.9 m ≈ | -21.9 m ≈ | -17.5 m ≈ | — | — | SEC (XBRL)· 16 Apr 2024derived |
| Investing cash flow | -87.0 k | -542.0 k | -168.0 k | -186.0 k | — | -24.3 m | SEC (XBRL)· 31 Mar 2026verified |
| Financing cash flow | 42.8 m | 10.3 m | 10.6 m | 17.3 m | 4.7 m | 54.9 m | SEC (XBRL)· 31 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- indicators available: 3 of at least 6
- score weight coverage: 18.8% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
05 Nov 2026Source: olivLaw, closing series
Market cap: 38.0 m USD
Key indicators
Coverage and freshness
Score by group
19% · Insufficient data
Estimated value range
unavailable — no valuation method could be computed
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
- DCF (discounted cash flow)unavailable · the input exists, but its latest figure is far older than the latest reported period: not used
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
no valuation method could be computed
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 3 of at least 6; score weight coverage: 18.8% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | unavailable | unavailable | — |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -55.1% | 0 (on a fixed band) | 44% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -61.7x | 0 (on a fixed band) | 33% |
| Current ratio · Balance sheet | 20.2x | 100 (on a fixed band) | 22% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet40/100 · 2/3 factors with a value
- Growth· partial0/100 · 1/2 factors with a value
- Quality· partialunavailable · 0/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partialunavailable · 0/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
STREAMEX CORP. (STEX). Latest full fiscal year: 2024; data up to 2026-06-30.
Figures computed from the financial statements: revenue 40.0 k USD in 2024; YoY growth 122.2%; ROE -705.4%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (indicators available: 3 of at least 6; score weight coverage: 18.8% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Current ratio: 20.2x
What contradicts it
- Revenue CAGR 3Y: -55.1%
- Interest coverage: -61.7x
Not assessed (insufficient data or a ratio without meaning): ROIC, Net margin, FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Security & Commodity Brokers, Dealers, Exchanges & Services (SIC 6200) · same industry (4-digit SIC) · compared with 15 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ICEIntercontinental Exchange, Inc. | 97.2 bn | 23.7 | 14.2% | 29.6% | +7.5% | +11% / +53% |
| NDAQNasdaq, Inc. | 59.3 bn | 29.2 | 17.4% | 22.8% | +11.6% | +17% / +91% |
| CBOECboe Global Markets, Inc. | 36.8 bn | 25.1 | 27.4% | 28.0% | +15.1% | +37% / +94% |
| LPLALPL Financial Holdings Inc. | 23.4 bn | 17.3 | 25.7% | 6.8% | +37.2% | −15% / +35% |
| SNEXStoneX Group Inc. | 6.5 bn | 12.3 | 21.9% | 0.3% | +32.5% | +33% / +196% |
| MRXMarex Group Ltd | 4.7 bn | 16.8 | 28.7% | 14.5% | +26.9% | +87% / unavailable |
| TOPTop Financial Group Limited | 438.2 m | — | -1.0% | -23.3% | +41.9% | +113% / −46% |
| EBONEbang International Holdings Inc. | 182.3 m | — | -5.6% | -215.6% | +11.4% | −52% / −75% |
| GSIWGarden Stage Limited | 162.5 m | 7.5 | -89.5% | -190.1% | +33.2% | −65% / unavailable |
| WTFWaton Financial Limited | 94.5 m | — | -87.9% | -136.7% | +48.8% | −41% / unavailable |
| STEXStreamex Corp. | 38.0 m | — | -705.4% | — | +122.2% | −93% / −92% |
| SOSSOS Limited | 20.9 m | — | -22.7% | -63.1% | −33.3% | −85% / −100% |
| CMECme Group Inc. | — | 25.1 | 16.1% | 63.3% | +6.4% | +9% / +41% |
| TWTradeweb Markets Inc. | 0 | 29.9 | 14.1% | 39.8% | +18.9% | +17% / +32% |
| PLUTPlutus Financial Group Limited | — | — | -55.3% | -377.3% | +6.9% | −64% / unavailable |
| BGCBGC Group, Inc. | — | 25.5 | 19.5% | 6.0% | +30.0% | +20% / +61% |
1- and 3-year price returns: for STEX from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 14 Aug 2026; since then the company filed 8-K (30 Sept 2026 · results), 8-K (21 Aug 2026 · results).
In brief
Streamex Corp. (formerly BioSig Technologies) has shifted from medical technology toward tokenized real-world asset infrastructure, starting with gold, following a May 2025 acquisition and the 2026 launch of its GLDY product. The company remains in a development stage, with revenue that is not yet significant and large operating losses, so its trajectory depends on product adoption and the regulatory framework.
SWOT
Strengths
- The company already runs a technology platform for token issuance, has launched a product, and eliminated its secured debt after its 2026 capital raise 12.
- Access to physical gold through the special vehicle and yield from leasing offer a model different from competitors based only on price exposure 1.
- Technical experience in signal processing and software development provides a basis for the platform infrastructure 1.
Weaknesses
- Revenue is nearly non-existent and the company is still in development, with very large net losses relative to operating activity 12.
- Stock-based compensation dominated results, so the reported loss does not reflect operating activity alone 1.
- Proof-of-reserves and independent audit of gold holdings are not yet fully implemented, and tokens are not listed on an exchange 1.
Opportunities
- Extension to other metals and energy assets could diversify revenue sources if the platform and regulation allow it 1.
- Institutional partnerships for underwriting and placement could bring volume and credibility to tokenized products 1.
- If tokens develop secondary market liquidity, trading fees could become a recurring revenue source 1.
Threats
- Regulatory changes for tokens and trading venues could halt or delay product launches 1.
- A decline in the gold price could reduce demand for GLDY and affect the value of assets held 1.
- Dependence on one leasing counterparty and one custody arrangement could expose the company to major operational disruption 2.
Risks
- Development stage with no significant revenuehigh
The company has stated it has not generated material revenue from the Streamex platform and will incur substantial costs before any revenue-generating activity 1.
- Token regulationhigh
Products could be treated as securities or commodities, which could require licences, transfer restrictions or suspension of offerings 1.
- Custody and reserve verificationhigh
Gold may be held unallocated and not linked to individual bars, and live proof-of-reserves is not yet fully implemented 1.
- Dilution and convertible instrumentsmedium
Convertible debt issued in 2025 produced dilution and accounting volatility, and similar financings in future could have similar effects 1.
- Concentration of leasing incomemedium
Gold lease income comes almost entirely from one counterparty, and a change in that relationship could eliminate the current source of income 2.
Investment thesis
What would need to be true (bull case)
- If gold tokenization becomes an accepted category for investors and regulators, Streamex could benefit from having already launched its product and built operating infrastructure 12.
- The financial structure has improved after the offering and debt repayment, which could give the company time to validate its business model 12.
- Expansion to other tangible assets could turn the platform into a broader infrastructure provider for real-world assets if adoption grows 1.
What would break the thesis
- The company has not yet generated significant revenue, and reported losses have been very large, which could require new financing on terms less favorable to shareholders 12.
- The regulatory framework for tokens is uncertain, and a restrictive interpretation could limit or delay new product launches 1.
- Custody and reserve evidence are not yet complete, and dependence on a few counterparties could expose the company to major operational risks 12.
What to watch
- Development of gold lease income and the volume of GLDY issuedQ3 2026
- Status of live proof-of-reserves implementation and independent audit of gold holdings2026
- Decision on the strategic evaluation of the ViralClear and BioSig AI subsidiariesnext 10-K
- Evolution of the regulatory framework for gold-linked tokens and trading platforms2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 14 Aug 2026; since then the company filed 8-K (30 Sept 2026 · results), 8-K (21 Aug 2026 · results).
The business
Streamex Corp. has two principal lines of business: real-world asset (RWA) tokenization, centered on the Streamex Exchange platform acquired in May 2025, and biomedical technology, represented by the PURE EP™ electrophysiology platform. The company describes its platform as institutional-grade infrastructure for issuing, trading and custodying digital tokens backed by tangible assets, beginning with gold 1. Its main product, GLDY, represents fractional interests in a Cayman special purpose vehicle (SPV) that holds physical gold and participates in a gold leasing program, with each token corresponding to one troy ounce 1. According to the latest quarterly report, it was officially launched in February 2026 and generated gold lease income of 146 thousand USD in the second quarter of 2026 2.
The intended revenue model includes token issuance fees, secondary trading fees, spreads from gold yield and, over the longer term, listing and private placement fees 1. Through fiscal 2025, the company had not reported revenue from the Streamex platform, and revenue from the medical business had been immaterial, indicating an activity still in the development phase 1. The corporate structure also includes majority-owned subsidiaries that, at the time of the reports, were under strategic evaluation, such as ViralClear and BioSig AI 1.
Financially, fiscal 2025 was dominated by non-cash charges: general and administrative expenses reached 67.5 million USD, largely stock-based compensation, and the net loss attributable to common stockholders was 462.8 million USD 1. Meanwhile, the company raised capital through an underwritten public offering in January 2026 with gross proceeds of 40.25 million USD, and in February 2026 it settled its secured convertible debentures for an aggregate cash payoff of 38.9 million USD 1.
Segments
Real-world asset tokenization (Streamex)
The main segment, operated through Streamex Exchange and the GLDY vehicle, is in its launch phase. Revenue is still small, and the company has said the activity is in a development stage, with operating losses expected in the coming period 12.
Biotechnology (PURE EP™)
The medical activity, related to cardiac signal processing, has been redirected toward research into software algorithms and is no longer a strategic priority. Revenue from this activity has not been significant, and the company is evaluating strategic alternatives for it 1.
Subsidiaries under evaluation
ViralClear and BioSig AI, majority-owned subsidiaries of the company, are currently dormant or with operations on hold, and management is evaluating strategic options for them 1.
Market context
Real-world asset tokenization is an emerging segment of digital financial infrastructure. Companies in this area could, in principle, offer transparent custody, faster settlement and fractional access to gold-linked products, but adoption remains uncertain 1. Gold itself serves as a safe-haven asset and attracts retail, institutional and sovereign investors, which could support demand for tokenized products if regulation and custody infrastructure mature 1.
The market for Streamex is still small, and reported quarterly revenue is modest relative to expenses 2. Medium-term success would depend on the volume of GLDY issued, liquidity in the secondary market and expansion into other asset classes such as industrial metals or energy royalties 1.
Trends
- Token regulationheadwind
The classification of tokens as securities or commodities, along with requirements for broker-dealers and alternative trading systems, could raise compliance costs or limit product offerings if authorities adopt restrictive interpretations 1.
- Institutional interest in digital assetstailwind
Financial institutions are increasingly exploring distributed ledger systems for settlement and custody, which could open distribution channels for products such as GLDY 1.
- Gold price movementsmixed
Demand for GLDY is directly linked to the gold price; a significant decline or higher volatility could reduce investor interest and affect the value of the company's assets 1.
- Dependence on one leasing counterpartyheadwind
Almost all gold lease income comes from a single counterparty, so any change in that relationship could have a major impact on current revenue 2.
Competitive position
Competition includes real-world asset tokenization platforms, issuers of tokenized gold-linked products and exchange-traded funds offering gold exposure. The available sources do not identify direct competitors in detail, and the company stresses that the market is emerging and adoption is not yet validated 1.
The advantages the company cites are settlement speed, transparency and the ability to offer leasing yield to investors who traditionally lacked access to such products. However, the absence of live proof-of-reserves and an independent audit of bullion could be a disadvantage against rivals offering those assurances 1.
- Real-world asset tokenization platforms
Companies issuing tokens for tangible assets that compete for the same investors and custody infrastructure; the sources do not name them explicitly.
- Gold funds and gold exposure products
Traditional vehicles such as exchange-traded funds offer gold exposure without tokenization; the sources cite them as a general alternative.
- Gold leasing counterparty
A counterparty the company depends on for leasing revenue; the relationship is a dependency as much as a competitor.
- Institutional digital asset issuers
Providers of custody and trading infrastructure for digital assets that may compete for institutional partnerships.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report09 Oct 2026Delisting notice · Financial statements and exhibits
- Current report30 Sept 2026Results of operations · Financial statements and exhibits
- Current report21 Aug 2026Results of operations · Regulation FD disclosure · Financial statements and exhibits
- Quarterly report14 Aug 2026
- Current report04 Aug 2026Departure or appointment of officers
- Current report13 Jul 2026Item 4.01 · Financial statements and exhibits
- Current report28 May 2026Other events · Financial statements and exhibits
- Current report27 May 2026Other events · Financial statements and exhibits
- Quarterly report14 May 2026
- Current report04 May 2026Departure or appointment of officers · Financial statements and exhibits
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Streamex Corp. · 31 Mar 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Streamex Corp. · 14 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.